Dilon Technologies, a provider of gamma imaging system optimized for early breast cancer detection, has signed a three-year agreement with a group purchasing organization MedAssets Supply Chain Systems, a MedAssets company.
Subscribe to our email newsletter
The agreement, with an effective date of June 1, 2008 provides MedAssets’s customers access to Dilon’s cornerstone product, The Dilon 6800 gamma camera.
The Dilon 6800 performs a molecular breast imaging technique called breast-specific gamma imaging, which can detect lesions independent of tissue density and discover very early stage cancers, according to Dilon.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.